Healthcare


Pharmaceuticals Manufacturing

Published: 8 Jun 2018

The power of data and market trends impacting pharmaceutical manufacturing and R&D facilities

Introduction

The global pharmaceutical industry is witnessing a surge in CEO confidence from US tax reforms, turbulent equity markets, and the strengthening global economy. The growth of the pharmaceutical industry is boosted by healthcare digitalization and democratization, creating an explosion in patient data, and the emergence of value-based reimbursement models. The convergence of biopharmaceuticals, drug delivery devices, and companion diagnostics—enabled by digital connectivity—is driving regulatory and commercial changes in many exciting ways for the industry.

Sign in to read the rest of this article

Not signed up? Register now Forgot your password?

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..